Efferon
The Efferon company develops devices with polymer sorbents that help purify the blood during severe conditions of patients with COVID-19
Efferon has raised €4.8M across 2 funding rounds from 2 investors, most recently a Seed round in May 2026. Based in Villach, Austria; active in Healthtech. Data as of 28 Oct 2026.
Villach, Austriaefferon.com ↗
Total raised
€4.8M
€4,785,255
Funding rounds
2
Investors
2
distinct backers
Active since
2021-07
latest 2026-05
Funding by year
EUR raised per year · 2026 YTDEfferon — funding by year — interactive chart.
Data table
| Efferon — funding by year | |
|---|---|
| 2021 | €2.3M |
| 2026 | €2.5M |
Signals
Medium confidenceRaise-next likelihood38
base rate 44% for Seed
- ▼ Raised very recently
Exit likelihood7
base rate 11% (2+ rounds)
- ▲ 5y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: too soon vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-05-21 | Seed | €2.5M | Private Investors | View deal → |
| 2021-07-15 | Other | €2.3M | Fix Ventures | View deal → |
Investors
2Fix VenturesPrivate Investors
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Oura Health€779MFinland · Healthtech
Global coverage: FundingData